PRODUCTS

Introduction to Covalab's Antibodies and Related Products.

CovalAb is a company-oriented antibody development and production to most members of key protein families such as Autophagy, Cancer, Ion Channels, Signal Transduction, Stem Cells and other fields of research.

Unique and Innovative Content of Antibodies to Post-translational Modifications and Related Proteins.

CovalAb's focus is antibodies to site specific Post-translation Modification of Proteins (PTM) and the antibodies to the chemically modified antigens. CovalAb's antibody catalogue includes unique antibodies that were developed as of its own research projects or as a result off-shoots of fundamental research projects carried out in collaboration with academics in University laboratories.

CovalAb offers high quality antibodies to different PTMs and also to more than 2000 different protein targets. Every month more than 50 new antibodies are released after extensive characterization and validation. An additional several thousand antibodies are currently screened and characterized.

The main objective of CovalAb is to provide scientists with an extensive collection of innovative and high quality antibodies for research and diagnostic applications

OUR LATEST PRODUCTS

Please choose the product you're interested in below.